AeroLeads people directory · profile

Brian Fox Email & Phone Number

Head of Computational Biology at Xaira Therapeutics
Location: Seattle, Washington, United States 8 work roles 2 schools
LinkedIn matched
✓ Verified August 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Head of Computational Biology
Location
Seattle, Washington, United States
Company size

Who is Brian Fox? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Brian Fox is listed as Head of Computational Biology at Xaira Therapeutics, a with 174 employees, based in Seattle, Washington, United States. AeroLeads shows a matched LinkedIn profile for Brian Fox.

Brian Fox previously worked as Scientific Director at Bristol-Myers Squibb and Founder at Needle Genomics Llc. Brian Fox holds Doctor Of Philosophy (Ph.D.), Biochemistry from University Of Washington.

Company email context

Email format at Xaira Therapeutics

This section adds company-level context without repeating Brian Fox's masked contact details.

Xaira Therapeutics

Review company-level records connected to Brian Fox before choosing the right outreach path.

Profile bio

About Brian Fox

• Mission driven to improve the lives of patients• Leverages extensive computational biology experience in target discovery, biomarker discovery, and translational research. Areas include immuno-oncology, cell therapy, neuroscience, and autoimmunity. Strong individual technical skills in gene expression analysis, genomics, data science, visualization, web application development, machine learning and large language models• Collaborates broadly and excels in communications to strategically align efforts across wet lab, dry lab and executive leadership. Serves as a highly effective scientific and business leader in large or small and diverse organizations• Invests in development of scientists through engagement with organization goals and a focus on impacting projects• Thrives in high-paced environment and has a demonstrated ability and eagerness for continuous learning and challenges

Current workplace

Brian Fox's current company

Company context helps verify the profile and gives searchers a useful next step.

Xaira Therapeutics
Xaira Therapeutics
Head of Computational Biology
Seattle, WA, US
Website
Employees
174
AeroLeads page
8 roles · 36 years

Brian Fox work experience

A career timeline built from the work history available for this profile.

Scientific Director

Lawrence Township, Nj, Us

Leading a computational biology team in the Informatics and Predictive Sciences department working with the IO and Cell Therapy Thematic Research Center; team members and I perform exploratory analyses for discovery, pre-clinical, and translational activities. We use datasets such as bulk and single cell RNA-seq on solid tumor and sorted immune cells, flow cytometry on blood and bone marrow cells, multiplex IHC of solid and heme tumors, CAR-T expansion, disease genetics, and blood cytokines. Participate in cross-functional teams related to cellular therapy strategy, biotherapeutics and small molecule discovery, and translational programs. Perform gene expression analysis using TCGA and single cell datasets to predict responsive patients across cancer indications for internal and partner immuno-oncology clinical programs. Use learnings from analysis of T cell exhaustion datasets to enable identification of new targets, inform in vitro target validation assays, and interpret CAR-T expansion and response in the clinic. [Originally hired at Celgene, now at BMS through acquisition][Consultant, 2015; Principal Scientist, 2015-2018; Senior Principal Scientist, Nov 2018; Director, March 2020-]

Founder

Develop and maintain a gene expression atlas web application for use by biologists. Application allows users to search for differentially expressed genes, generate gene expression plots, discover and test potential biomarkers, perform sample clustering analysis. It also provides the data and plots with a user-friendly API so that other tools can incorporate the data. License the software to several biotech companies.

Principal Bioinformatics Scientist

Seattle, Washington, Us

• Statistical analysis and reporting of clinical data for FDA filing of a new diagnostic gene expression test for sepsis, SeptiCyte(c) Lab, later approved in 2017.• Process and analyze many public gene expression datasets with the goal of finding new signatures for sepsis or other infections in various settings. (published June 2017, Scientific Reports, see below for link)

Nov 2014 - Jul 2015

Principal Scientist, Team Leader - Bioinformatics

Bagsværd, Dk

• Lead well respected bioinformatics team whose focus included many aspects of the autoimmune drug discovery process such as target discovery, biomarker identification, mechanism of action, and patient clinical response. The team used a wide combination of RNA expression (RNA-seq and microarray), genetic (GWAS and whole genome), FACS and pathway data as our primary sources for this work.• Identified need and took the initiative to develop a web-based tool to integrate and share all of the relevant public and internal RNA-seq profiling data with the various biology groups across company global sites. This web database enabled team members and biologists to introduce multiple new targets into the drug discovery pipeline.• Participated in several cross functional strategy teams including: the rheumatoid arthritis target discovery program, big data, software evaluation, human genetics, in-licensing and the lupus (SLE) disease focus group.• Utilized data analysis techniques such as principal component analysis (PCA), clustering approaches (hierarchical clustering, k-means), differential expression tests, linear models, machine learning, gene modules, cell type deconvolution, and pathway analysis.[Senior Scientist, 2009-2014; Principal Scientist, 2014]

Jan 2009 - Nov 2014

Senior Computational Biologist

Seattle, Washington, Us

• Integral member of Computational Biology group, involved with many different research and discovery projects in areas of immunology and oncology. The group was the major source of novel drug candidates and value for the entire company. • Example activities: computational assisted discovery of novel protein therapeutics (data management and integration, web interface design, sequence alignments, HMM algorithms), working with biologists on specific projects and interdepartmental discovery strategy teams, global EST and microarray gene expression statistical analysis, proteomics tool development, 3D protein modeling, public data downloading services and various other support activities.• Played a significant role in the discovery of drug candidate interferon-lambda (IL29), which had positive results in recent clinical trials for Hepatitis C and was the primary asset in the multi hundred million dollar acquisition of ZymoGenetics by BMS.[Associate Computational Biologist, 2000-2001; Computational Biologist 2001-2005; Senior Computational Biologist, 2005-2009]

Mar 2000 - Jan 2009

Graduate Research Assistant

Seattle, Wa, Us

• Worked to understand the active conformation of blood coagulation Factor XIII in the lab of advisor David Teller, Ph.D. Used X-ray crystallography to determine the structure of this enzyme under several different conditions.• Assisted in the highly delicate process of crystal handling, synchrotron data collection, and the initial steps for the eventual structure determination of the rhodopsin protein - the first crystal structure of a GPCR. This publication has been cited several thousand times due to the enormous importance of this class of proteins in biomedicine.• In the lab of David Baker, Ph.D., worked on computational research projects associated with protein fold prediction. Developed secondary structure packing descriptive statistics used in the early and groundbreaking versions of the Rosetta software, which was the best performing protein fold prediction programs.• Projects involved genetic algorithms, monte carlo methods, 3D model feature extraction, phylogenetic analyses, 3D model visualization, FFTs, least squares minimization and other statistical and numeric methods.

Sep 1995 - Mar 2000

Undergraduate Research Assistant

Ithaca, Ny, Us

• Visualized a dataset of wind streak patterns derived from Mars Viking orbital photos overlaid on surface topographical maps (Peter Gierasch, Ph.D.).• Examine images and redshifts of nearby galaxies to calculate the relative motion of the Milky Way (Martha P Haynes, Ph.D.)• Applied statistical methods to determine the likelihood of a relationship between the visual imagery and high energy observations of gas embedded hot stars (Katy Garmany, Ph.D. @ Boulder).

1991 - 1993 ~2 yrs
2 education records

Brian Fox education

Doctor Of Philosophy (Ph.D.), Biochemistry

University Of Washington

Bachelor'S Degree, Physics

Cornell University
FAQ

Frequently asked questions about Brian Fox

Quick answers generated from the profile data available on this page.

What company does Brian Fox work for?

Brian Fox works for Xaira Therapeutics.

What is Brian Fox's role at Xaira Therapeutics?

Brian Fox is listed as Head of Computational Biology at Xaira Therapeutics.

Where is Brian Fox based?

Brian Fox is based in Seattle, Washington, United States while working with Xaira Therapeutics.

What companies has Brian Fox worked for?

Brian Fox has worked for Xaira Therapeutics, Bristol-Myers Squibb, Needle Genomics Llc, Immunexpress Inc., and Novo Nordisk.

How can I contact Brian Fox?

You can use AeroLeads to view verified contact signals for Brian Fox at Xaira Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Brian Fox attend?

Brian Fox holds Doctor Of Philosophy (Ph.D.), Biochemistry from University Of Washington.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.